Valsartan Recalls Resulted In Significant Drop In Use, As Well As Confusion and Concerns Among Doctors, Patients
A new study suggests there was confusion over which drugs to use following the initial valsartan recalls due to NDMA contamination.…
A new study suggests there was confusion over which drugs to use following the initial valsartan recalls due to NDMA contamination.…
In July 2018, it was discovered that certain generic valsartan pills sold for years may contain impurities that increase the risk of users developing liver cancer, kidney cancer and other side effects. …
A panel of federal judges has ordered all losartan and irbesartan recall lawsuits folded into consolidated valsartan litigation.…
Aurobindo reports that the FDA has found more problems at its India production facilities during inspections last month in the wake of valsartan recalls.…
The hypertension drug Benicar has been linked to cases of sprue-like enteropathy, which causes chronic diarrhea, weight gain and other serious gastrointestinal problems.…
The FDA has issued a warning letter to Torrent Pharmaceuticals regarding problems at a losartan manufacturing plant in India as part of its investigation into contaminated hypertension drugs.…
A new analysis warns that the FDA has only screened a quarter of all valsartan and similar high blood pressure medications for cancer-causing impurities.…
The federal judge overseeing valsartan recall litigation has approved Plaintiff Fact Sheets for both individual and class action claims that the generic hypertension drugs contained cancer-causing impurities.…
A status conference this week will discuss whether losartan and irbesartan lawsuits should be added to a valsartan recall lawsuit MDL, as all three drugs saw massive recalls over cancer-causing impurities.…
A losartan lawsuit claims generic versions of the drug were tainted with impurities which caused colon cancer.…